May 22, 2024

Internal Nasal Dilators Market High Growth Opportunities, Emerging Trends, Industry Review, Forecast Till 2031

Internal nasal dilators are thin, adhesive strips that adhere to the nose to gently pull open nasal passages, thereby making breathing more comfortable. By helping to open nasal passages and reduce nasal congestion and restriction, internal nasal dilators promote efficient breathing during exercise, sleep, or periods of nasal congestion from allergies or colds. Users simply insert and adjust the flexible dilator strips within the nostrils for up to 24-hour wearing time. The convenience and effectiveness of internal nasal dilators has made them a popular solution for improving breathing comfort.

The global Internal Nasal Dilators Market is estimated to be valued at US$ 10.11 Bn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Get more insights on this topic:

Market key trends:

One of the key trends in the internal nasal dilator market is the development and launch of new product variants. Manufacturers are focusing on developing new product features such as low-profile designs for less visibility, added flexibility for improved comfort, antimicrobial protection, and longer wear time up to 24 hours. For example, in 2022, Rhinomed launched Propa’Clear, an internal nasal dilator featuring Rhinomed’s proprietary Flexitube technology for flexibility and breathability. Another example is Nasanita, which launched a new zinc-infused internal nasal dilator in 2021 to promote nasal health with the natural antimicrobial properties of zinc. Such product innovations are expected to further accelerate the demand for internal nasal dilators over the forecast period.

Porter’s Analysis

Threat of new entrants: Low since this is a well-established market, requires large capital investments and there are regulatory barriers.

Bargaining power of buyers: Moderate as major customers are hospitals and individuals. Buyers have some influence over prices due to growing availability of alternatives.

Bargaining power of suppliers: Moderate as raw materials are commoditized but some key components have specialized manufacturers with strong brands.

Threat of new substitutes: Low as internal nasal dilators are convenient and effective for frequent or long-term use.

Competitive rivalry: High due to presence of large number of global and regional players offering similar products. Intense competition on pricing and product differentiation.

Key Takeaways

The global Internal Nasal Dilators market is expected to witness high growth over the forecast period of 2023 to 2030.
Regionally, North America accounted for the largest market share in 2024 due to growing awareness and increasing cases of nasal congestion. Asia Pacific is expected to grow at the fastest pace owing to large patient pool and rising healthcare expenditure.

Key players operating in the Internal Nasal Dilators market are Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, LLC, Sol-Millennium, UltiMed Inc., VOGT MEDICAL, Retractable Technologies, Inc., Dmcmedical, BIOCORP, Hindustan Syringes & Medical Devices Ltd, Owen Mumford Ltd., B. Braun SE, Terumo Europe NV, Smiths Group plc, Merit Medical Systems, Nipro Corporation, GPC Medical Ltd., AdvaCare Pharma. Becton, Dickinson and Company is a leading provider of nasal dilators.


  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it